FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Diana Martin

Research Profile

Living Beings

Disorders

Geographic Areas

New Zealand

Chemicals & Drugs

Concepts & Ideas

Immunization Schedule

Phenomena

Physiology

Blood Bactericidal Activity

Procedures

Co-author Network

Publications

TOP 3
Catherine Jackson; Diana Lennon; Philipp Oster; Stewart Reid; Joanna Stewart; Sharon Wong; Jacqueline Yan; Ellen Ypma; Diana Martin
Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.
Anne McNicholas; Yvonne Galloway; Diana Martin; Kerry Sexton; Jane O'Hallahan
Surveillance of vaccine breakthrough cases following MeNZB vaccination.
Jamie Hosking; Kumanan Rasanathan; Florina Chan Mow; Catherine Jackson; Diana Martin; Jane O'Hallahan; Philipp Oster; Ellen Ypma; Stewart Reid; Ingeborg S Aaberge; Sue Crengle; Joanna Stewart; Diana Lennon
Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Diana Martin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Catherine Jackson; Diana Lennon; Philipp Oster; Stewart Reid; Joanna Stewart; Sharon Wong; Jacqueline Yan; Ellen Ypma; Diana Martin
Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers.
Archives of disease in childhood 2011;96(8):744-51.
2008: Anne McNicholas; Yvonne Galloway; Diana Martin; Kerry Sexton; Jane O'Hallahan
Surveillance of vaccine breakthrough cases following MeNZB vaccination.
The New Zealand medical journal 2008;121(1272):38-46.
2007: Jamie Hosking; Kumanan Rasanathan; Florina Chan Mow; Catherine Jackson; Diana Martin; Jane O'Hallahan; Philipp Oster; Ellen Ypma; Stewart Reid; Ingeborg S Aaberge; Sue Crengle; Joanna Stewart; Diana Lennon
Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.
Clinical and vaccine immunology : CVI 2007;14(11):1393-9.
2007: Elisabeth Wedege; Karin Bolstad; Audun Aase; Tove K Herstad; L McCallum; Einar Rosenqvist; Philipp Oster; Diana Martin
Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.
Clinical and vaccine immunology : CVI 2007;14(7):830-8.
2007: Hamish M Lala; Graham D Mills; Kevin Barratt; John Bonning; Noel E Manikkam; Diana Martin
Meningococcal disease deaths and the frequency of antibiotic administration delays.
The Journal of infection 2007;54(6):551-7.
2007: Philipp Oster; Jane O'Hallahan; Ingeborg S Aaberge; Sandrine Tilman; Ellen Ypma; Diana Martin
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand.
Vaccine 2007;25(16):3075-9.
2007: Sharon Wong; Diana Lennon; Catherine Jackson; Joanna Stewart; Stewart Reid; Sue Crengle; Sandrine Tilman; Ingeborg S Aaberge; Jane O'Hallahan; Philipp Oster; Kim Mulholland; Diana Martin
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
The Pediatric infectious disease journal 2007;26(4):345-50.
2006: N Ruijne; Rod A Lea; Jane O'Hallahan; Philipp Oster; Diana Martin
Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants.
Clinical and vaccine immunology : CVI 2006;13(7):797-801.
2006: V Thornton; Diana Lennon; Kumanan Rasanathan; Jane O'Hallahan; Philipp Oster; Joanna Stewart; Sandrine Tilman; Ingeborg S Aaberge; Berit Feiring; H Nokleby; Einar Rosenqvist; K White; Stewart Reid; Kim Mulholland; M J Wakefield; Diana Martin
Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.
Vaccine 2006;24(9):1395-400.
2005: Lily Yang; Mark Thomas; Andrew F Woodhouse; Diana Martin; John D Fraser; Thomas Proft
Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome.
Journal of clinical microbiology 2005;43(7):3570-3.
2005: K Dyet; A Devoy; R McDowell; Diana Martin
New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
Vaccine 2005;23(17-18):2228-30.
2005: Diana Martin; L McCallum; A Glennie; N Ruijne; P Blatchford; Jane O'Hallahan; Philipp Oster
Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials.
Vaccine 2005;23(17-18):2218-21.
2005: Jane O'Hallahan; Diana Lennon; Philipp Oster; Robbie Lane; Stewart Reid; Kim Mulholland; Joanna Stewart; Liane Penney; Teuila Percival; Diana Martin
From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease.
Vaccine 2005;23(17-18):2197-201.
2005: Philipp Oster; Diana Lennon; Jane O'Hallahan; Kim Mulholland; Stewart Reid; Diana Martin
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.
Vaccine 2005;23(17-18):2191-6.
2004: Kerry Sexton; Diana Lennon; Philipp Oster; Ingeborg S Aaberge; Diana Martin; Stewart Reid; Sharon Wong; Jane O'Hallahan
Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand.
The New Zealand medical journal 2004;117(1200):1 p preceding U1027.
2004: Kerry Sexton; Diana Lennon; Philipp Oster; Sue Crengle; Diana Martin; Kim Mulholland; Teuila Percival; Stewart Reid; Joanna Stewart; Jane O'Hallahan
The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
The New Zealand medical journal 2004;117(1200):U1015.
2000: Thomas Proft; S L Moffatt; K D Weller; A Paterson; Diana Martin; John D Fraser
The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation.
The Journal of experimental medicine 2000;191(10):1765-76.
1999: C Bremner; Diana Lennon; Diana Martin; M Baker; H Rümke
Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine.
The New Zealand medical journal 1999;112(1091):257-9.